Literature DB >> 8295399

Unreliability of platelet glucose-6-phosphatase for the diagnosis of glycogen storage disease type Ia.

J D Goldberg1, S C Treleaven, M Koresawa, T Simpson, M S Golbus.   

Abstract

The diagnosis of glycogen storage disease type Ia currently uses enzyme analysis of liver tissue. This requires liver biopsy in the at-risk neonate or fetus. Conflicting reports have appeared in the literature on the use of peripheral platelet glucose-6-phosphatase activity for the diagnosis of this disorder. We have applied a sensitive radiometric assay system to the measurement of glucose-6-phosphatase activity in peripheral platelets. Two families with affected members were analysed, revealing no differences in glucose-6-phosphatase activity as compared with control values. Platelet measurement of glucose-6-phosphatase does not appear to be useful for the diagnosis of glycogen storage disease type Ia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295399     DOI: 10.1007/BF00714276

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

Review 1.  The molecular basis of the hepatic microsomal glucose-6-phosphatase system.

Authors:  A Burchell; I D Waddell
Journal:  Biochim Biophys Acta       Date:  1991-04-17

2.  Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.

Authors:  Y Oka; T Mitsuyama; B Nagai; S Arashima; I Ohkubo; I Matsuda
Journal:  Clin Chim Acta       Date:  1978-08-01       Impact factor: 3.786

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Ontogeny of fetal liver glucose-6-phosphatase activity.

Authors:  T J Simpson; M Koresawa; W A Hogge; W Holzgreve; M S Golbus
Journal:  Prenat Diagn       Date:  1987-11       Impact factor: 3.050

5.  Platelet glucose-6-phosphatase activity in patients with von Gierke's disease and their parents.

Authors:  H Negishi; Y Morishita; S Kodama; T Matsuo
Journal:  Clin Chim Acta       Date:  1974-06-19       Impact factor: 3.786

6.  The prenatal determination of glucose-6-phosphatase activity by fetal liver biopsy.

Authors:  M S Golbus; T J Simpson; M Koresawa; Z Appelman; C E Alpers
Journal:  Prenat Diagn       Date:  1988-07       Impact factor: 3.050

7.  Insignificance of gluconeogenesis in human blood platelets.

Authors:  J Schrijver
Journal:  Eur J Clin Invest       Date:  1975-02       Impact factor: 4.686

8.  The diagnostic value of thrombocytic glucose-6-phosphatase in patients with von Gierke's disease and its heterozygotes.

Authors:  K Soyama; N Shimada; T Kusunoki; T Nakamura
Journal:  Clin Chim Acta       Date:  1973-03-30       Impact factor: 3.786

9.  Urate production in heterozygotes for glucose-6-phosphatase deficiency.

Authors:  D Stormont; C Davies; B T Emmerson
Journal:  Clin Chim Acta       Date:  1976-09-06       Impact factor: 3.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.